These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11590257)

  • 1. Advances in nephrology: successes and lessons learnt from diabetes mellitus.
    Ritz E
    Nephrol Dial Transplant; 2001; 16 Suppl 7():46-50. PubMed ID: 11590257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing anaemia and diabetes: a future challenge for nephrologists.
    Ritz E
    Nephrol Dial Transplant; 2005 Jun; 20 Suppl 6():vi21-5. PubMed ID: 15958822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and management of patients with early chronic kidney disease.
    Rossert J; Fouqueray B
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S6-12. PubMed ID: 15103542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic nephropathy. Prevention and early referral.
    Pylypchuk G; Beaubien E
    Can Fam Physician; 2000 Mar; 46():636-42. PubMed ID: 10752002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hospital-primary care teamwork in nephrology: 'preventive' epidemiology of diabetic nephropathy].
    Russo D; Vico A; Monterisi F; Biga ML; Falanga R; Mancini A; Teutonico A; Losappio R; Gruppo di Integrazione Territtorio-Ospedale In Nefrologia GI
    G Ital Nefrol; 2007; 24 Suppl 38():83-6. PubMed ID: 17922455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaemia in diabetes.
    Thomas S; Rampersad M
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S13-7. PubMed ID: 15103543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies in anaemia management: ACORD (Anaemia CORrection in Diabetes) trial.
    Laville M;
    Acta Diabetol; 2004 Mar; 41 Suppl 1():S18-22. PubMed ID: 15103544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetic nephropathy: strategies for prevention].
    Romero R
    Nefrologia; 2002; 22 Suppl 1():46-50. PubMed ID: 11987670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE.
    Liew A; Bavanandan S; Prasad N; Wong MG; Chang JM; Eiam-Ong S; Hao CM; Lim CY; Lim SK; Oh KH; Okada H; Susantitaphong P; Lydia A; Tran HTB; Villanueva R; Yeo SC; Tang SCW
    Nephrology (Carlton); 2020 Oct; 25 Suppl 2():12-45. PubMed ID: 33111477
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on pathogenesis, markers and management of diabetic nephropathy.
    Mogyorósi A; Ziyadeh FN
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):243-53. PubMed ID: 8737860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diabetes mellitus, hypertension and kidney].
    Monhart V
    Vnitr Lek; 2008 May; 54(5):499-504, 507. PubMed ID: 18630636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE - EXECUTIVE SUMMARY.
    Liew A; Bavanandan S; Prasad N; Wong MG; Chang JM; Eiam-Ong S; Hao CM; Lim CY; Lim SK; Oh KH; Okada H; Susantitaphong P; Lydia A; Tran HTB; Villanueva R; Yeo SC; Tang SCW
    Nephrology (Carlton); 2020 Oct; 25 Suppl 2():3-11. PubMed ID: 33111476
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Strategies to reduce the progression of renal disease in patients with type II diabetes mellitus].
    Burgos Calderón R
    P R Health Sci J; 2001 Jun; 20(2):157-60. PubMed ID: 11561475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.